If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
371.80    2.60 (0.70%)
Bid:
371.20
Ask:
371.80
Spread: 0.60 (0.162%)
Market Cap: £1.97b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Form 8 (OPD) (Klepierre)

29 Mar 2018 16:35

RNS Number : 4861J
Hammerson PLC
29 March 2018
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Hammerson plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Offeror - KlΓ©pierre S.A.

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

28 MARCH 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

Hammerson plcIntu Properties plc

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

N/A

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

N/A

-

N/A

-

(2) Cash-settled derivatives:

Β 

N/A

-

N/A

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

-

N/A

-

Β 

TOTAL:

N/A

-

N/A

-

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

a) Share interests of connected advisers of Hammerson plc in KlΓ©pierre S.A.

Β 

JPMorgan Chase Bank, N.A. (Custody):

Β 

Class of relevant security

Ordinary shares

Interests

Short Positions

Number

%

Number

%

Relevant securities owned and/or controlled

245

0.00008%

N/A

-

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

29 March 2018

Contact name:

Sarah Booth

Telephone number:

44 (0) 20 7887 1000

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

The announcement above has been released on the SENS system of the Johannesburg Stock Exchange.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEZMGZFKLFGRZM
Date   Source Headline
12th Jul 202112:15 pmRNSDirector Declaration
12th Jul 202112:00 pmRNSDirector/PDMR Shareholding - Replacement
9th Jul 202111:30 amRNSNotice of Results
9th Jul 20219:00 amRNSDirector/PDMR Shareholding
5th Jul 20213:30 pmRNSNotice of Redemption Price
2nd Jul 202110:45 amRNSHolding(s) in Company
28th Jun 202111:00 amRNSHolding(s) in Company
24th Jun 20213:00 pmRNSHolding(s) in Company
23rd Jun 202111:30 amRNSHolding(s) in Company
21st Jun 202111:00 amRNSDirector Declaration
16th Jun 202111:00 amRNSHolding(s) in Company
14th Jun 20214:30 pmRNSHolding(s) in Company
7th Jun 202112:15 pmRNSDirector/PDMR Shareholding
4th Jun 20215:31 pmBUSEarly Repurchase(s)
4th Jun 20215:29 pmBUSEarly Repurchase(s)
4th Jun 20217:00 amRNSNotice of Exercise of Call Option
1st Jun 20214:45 pmRNSFinal Results of Bond Tender Offer
1st Jun 202110:30 amRNSBond Tender Offer - Indicative Results
1st Jun 202110:00 amRNSBlock listing Interim Review
28th May 202111:30 amRNSHolding(s) in Company
27th May 202112:00 pmRNSBond Tender Offer Update
27th May 20217:00 amRNSSustainability-Linked Bond Launch
26th May 20219:30 amRNSHolding(s) in Company
21st May 20214:30 pmRNSHolding(s) in Company
20th May 20219:45 amRNSBond Tender Offers
19th May 20214:30 pmRNSNotification of Transactions of Directors/PDMRs
19th May 202112:45 pmRNSCompletion of retail parks portfolio disposal
13th May 20219:00 amRNSTotal Voting Rights
10th May 20217:00 amRNSFinal Dividend and Enhanced Scrip Alternative
4th May 202112:28 pmRNSResult of AGM
27th Apr 20213:30 pmRNSDirector/PDMR Shareholding
21st Apr 20211:15 pmRNSDisposal
21st Apr 20219:30 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSDirectorate Change
20th Apr 20217:00 amRNSOperational and Rent Collection Update
19th Apr 20214:30 pmRNSDirector/PDMR Shareholding
15th Apr 20212:00 pmRNSHolding(s) in Company
15th Apr 20219:30 amRNSHolding(s) in Company
13th Apr 202112:15 pmRNSHolding(s) in Company
13th Apr 202111:30 amRNSHolding(s) in Company
12th Apr 20212:00 pmRNSHolding(s) in Company
12th Apr 20217:00 amRNSResponse to Press Speculation
8th Apr 20219:00 amRNSVirtual Shareholder Engagement Session
1st Apr 202110:20 amRNSHolding(s) in Company
1st Apr 202110:00 amRNSDirector/PDMR Shareholding
1st Apr 20219:45 amRNSCash Fractions for the Enhanced Scrip Dividend
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
29th Mar 202111:00 amRNSAnnual Report, Notice of AGM & Scrip Circular
29th Mar 20219:30 amRNSHolding(s) in Company
24th Mar 20213:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.